Innovative Biomarker Solutions
Pharmacogenomics is the use of a person’s genetic profile to more accurately predict the safety, toxicity, and efficacy of drugs with the ultimate goal of improving an individual’s treatment and prognosis. Successful implementation of pharmacogenomics in drug development requires carefully designed studies, well executed protocols, and detailed data analysis. Gentris works with clients to plan and carry out CLIA compliant, clinical pharmacogenomics studies that can accelerate the drug development process, minimize adverse drug reactions, deliver more predictable drug responses, and reduce the cost of clinical trials.
Learn more about our Biomarker Solutions: